CIK 0001455365 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
COGNITION THERAPEUTICS INC
Sign in to watch- Ticker
- CGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 412-481-2210
- Business address
- 2500 WESTCHESTER AVE, PURCHASE, NY, 10577
- Former names
- COGNITION THERAPUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion | +1,263,575 | 2,047,302 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion | +135,679 | 2,182,981 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Option exercise | +27,471 | $0.03 | $879 | 2,210,452 |
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Sale | −74.05 | $12.00 | $889 | 2,210,377 |
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion · Series A Convertible Preferred Stock | −1,319,408 | 0 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion · Series A-1 Convertible Preferred Stock | −333,333 | 0 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion · Series A-2 Convertible Preferred Stock | −882,233 | 0 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −4,087,046 | 0 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion · Series B-1 Convertible Preferred Stock | −438,854 | 0 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Option exercise · Warrant (right to buy) | −27,471 | 0 | ||
| 2021-10-13 | Breedlove Mark H. Director | Conversion | +44,806 | 44,806 | ||
| 2021-10-13 | Breedlove Mark H. Director | Conversion | +36,714 | 81,520 | ||
| 2021-10-13 | Breedlove Mark H. Director | Conversion | +225,281 | 306,801 | ||
| 2021-10-13 | Breedlove Mark H. Director | Conversion | +93,296 | 400,097 | ||
| 2021-10-13 | Breedlove Mark H. Director | Conversion | +4,354 | $0.03 | $139 | 404,451 |
| 2021-10-13 | Breedlove Mark H. Director | Sale | −11.74 | $12.00 | $141 | 404,439 |
| 2021-10-13 | Breedlove Mark H. Director | Conversion · Series A-1 Convertible Preferred Stock | −144,928 | 0 | ||
| 2021-10-13 | Breedlove Mark H. Director | Conversion · Series A-2 Convertible Preferred Stock | −118,835 | 0 | ||
| 2021-10-13 | Breedlove Mark H. Director | Conversion · Series B Convertible Preferred Stock | −826,278 | 0 | ||
| 2021-10-13 | Breedlove Mark H. Director | Conversion · Series B-1 Convertible Preferred Stock | −301,978 | 0 |
Page 12 of 13 · 247 trades